- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-dimer
- Ligands
- 7 x CPS: 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE(Non-covalent)
- 2 x EMV: (2E)-N-({3-[([3,3'-bithiophen]-5-yl)methoxy]phenyl}methyl)-N-ethyl-6,6-dimethylhept-2-en-4-yn-1-amine(Non-covalent)
EMV.4: 25 residues within 4Å:- Chain A: F.50, Q.52, Y.79, I.81, I.92, L.208, L.217, Y.219, L.229, P.299, L.300, T.301, G.302, L.353, L.357, F.361, F.379, P.389, V.390, L.393, L.403, H.406, F.407, V.410
- Ligands: FAD.5
21 PLIP interactions:21 interactions with chain A- Hydrophobic interactions: A:F.50, A:Y.79, A:I.92, A:L.208, A:L.217, A:L.217, A:Y.219, A:L.300, A:L.353, A:L.357, A:L.357, A:L.357, A:F.361, A:F.379, A:P.389, A:V.390, A:H.406, A:V.410
- Hydrogen bonds: A:Y.79
- pi-Stacking: A:F.50, A:Y.79
EMV.10: 23 residues within 4Å:- Chain B: F.50, Q.52, Y.79, I.81, I.92, L.208, L.217, Y.219, P.299, L.300, T.301, G.302, L.353, L.357, F.361, F.379, P.389, V.390, L.393, H.406, F.407, V.410
- Ligands: FAD.11
17 PLIP interactions:17 interactions with chain B- Hydrophobic interactions: B:F.50, B:Y.79, B:I.92, B:L.208, B:L.217, B:Y.219, B:L.300, B:L.353, B:L.357, B:L.357, B:L.357, B:F.361, B:F.379, B:P.389, B:H.406, B:V.410
- pi-Stacking: B:Y.79
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.5: 31 residues within 4Å:- Chain A: G.14, A.15, G.16, V.17, L.18, I.36, E.37, R.38, R.45, V.47, G.48, E.49, F.50, R.118, G.132, V.133, V.134, A.168, D.169, G.170, F.190, M.272, P.273, G.291, D.292, P.299, G.302, G.303, G.304, M.305
- Ligands: EMV.4
32 PLIP interactions:32 interactions with chain A- Hydrophobic interactions: A:V.47, A:V.47, A:F.190, A:M.272, A:P.299
- Hydrogen bonds: A:A.15, A:A.15, A:V.17, A:L.18, A:R.38, A:R.38, A:G.48, A:E.49, A:F.50, A:F.50, A:R.118, A:V.134, A:V.134, A:D.292, A:G.304, A:M.305, A:T.306
- Water bridges: A:G.16, A:R.45, A:G.170, A:A.293, A:R.297, A:R.297, A:G.303, A:A.308
- Salt bridges: A:R.45
- pi-Cation interactions: A:R.38
FAD.11: 30 residues within 4Å:- Chain B: G.14, G.16, V.17, L.18, I.36, E.37, R.38, R.45, V.47, G.48, E.49, F.50, R.118, G.132, V.133, V.134, A.168, D.169, G.170, F.190, M.272, P.273, G.291, D.292, P.299, G.302, G.303, G.304, M.305
- Ligands: EMV.10
30 PLIP interactions:30 interactions with chain B- Hydrophobic interactions: B:V.47, B:F.190, B:M.272, B:P.299
- Hydrogen bonds: B:V.17, B:L.18, B:R.38, B:R.45, B:R.45, B:G.48, B:E.49, B:F.50, B:F.50, B:R.118, B:V.134, B:V.134, B:D.292, B:G.304, B:M.305, B:T.306
- Water bridges: B:G.16, B:G.16, B:L.171, B:L.171, B:A.293, B:R.297, B:R.297, B:R.297, B:G.303
- pi-Cation interactions: B:R.38
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Padyana, A.K. et al., Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase. Nat Commun (2019)
- Release Date
- 2019-01-16
- Peptides
- Squalene monooxygenase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-dimer
- Ligands
- 7 x CPS: 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE(Non-covalent)
- 2 x EMV: (2E)-N-({3-[([3,3'-bithiophen]-5-yl)methoxy]phenyl}methyl)-N-ethyl-6,6-dimethylhept-2-en-4-yn-1-amine(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Padyana, A.K. et al., Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase. Nat Commun (2019)
- Release Date
- 2019-01-16
- Peptides
- Squalene monooxygenase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B